Calcul des parts de marché relative CBG
Transféré par
lobinjackCalcul des parts de marché relative CBG
Transféré par
lobinjackCommon questions
Alimenté par l’IAProduct D is labeled a 'dilemma product' because it is in an emerging market with high growth potential but currently contributes minimally to revenue. Investing in Product D involves risk due to its uncertain position, balancing between potential profitability and the threat of non-performance. Strategic decisions are critical to shift Product D from a dilemma to a star status .
Product C is strategically crucial as it dominates its category with a high market share, reflecting its role as a star. Though the market is maturing, CBG needs Product C to generate substantial profits to support less-profitable areas, fund growth initiatives, maintain liquidity, and sustain revenue from declining or low-performing products. Its role as a key profit center influences CBG's capability to invest in other potential growth areas .
Investing in emerging markets offers potential high return-on-investment due to growth opportunities but involves significant risks, including market volatility, increased competition, and uncertain demand. For Products D and E, the opportunities lie in attaining market leadership and high growth; however, these are coupled with investment costs and strategic management necessities to actualize potential gains without spreading resources too thin .
The relative market share of a product is calculated by dividing the market share of the company (CBG) by the market share of its main competitor (GBC). Specifically, it involves dividing the sales figures of the company's product by the sales figures of the competitor's product. For example, for Product A, the relative market share is calculated as 20,500 (CA CBG) divided by 35,600 (CA GBC), which equals 0.58 .
When developing Product E, CBG should assess market conditions, competitive positioning, potential growth rates, and investment needs. Understanding consumer trends, leveraging technological advancements, strategic marketing, and establishing robust distribution channels are crucial. Networking with stakeholders and continuous performance analysis are also vital to ensuring successful development .
Based on the BCG matrix, CBG should prioritize investments in Product C to maintain its dominant market position. Simultaneously, strategic allocation is needed to boost Product D's market presence, given its potential in an emerging market. Product A should be sustained as a revenue generator while exploring exit strategies or optimization for mature or decline-accentuated markets. Product E could receive measured investment to capitalize on potential growth without large risks .
Without 'cash cow' products—those with a high market share in a matured market providing steady cash flow—CBG faces financial instability. The lack of a reliable revenue source affects its ability to support other products financially, particularly those in developmental or declining phases, which strains capital flow and future investments .
CBG's product portfolio is imbalanced; it lacks cash cows, affecting its liquidity. Product C is a star with the highest market share but in a maturing market, requiring continued investment to maintain dominance. Dilemma Product D has growth potential in an emerging market but currently has little impact on revenue. Products A and B in decline and matured markets, respectively, need strategic management while maintaining significant revenue contributions, particularly from Product A, which accounts for a third of CBG's revenue .
In a matured market, Product B requires strategies focused on maintaining or increasing market share against competitors, optimizing costs, enhancing customer loyalty, and possibly innovating to differentiate from existing offerings. CBG needs to emphasize efficiency, competitive pricing, and incremental innovation to sustain profitability and prevent market share erosion .
Despite the declining market, maintaining Product A is rationalized by its substantial contribution to CBG's revenue, forming a third of the company's total revenue. Until viable alternatives or market expansions are realized, Product A remains critical for cash flow, aiding in financing emerging and growth-driven initiatives within CBG's product strategy .